News

Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing

Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing

Partnership Expansion Between Biodesix and Bio-Rad

Biodesix, Inc. (NYSE: BDSX), a prominent diagnostics solutions company, has recently strengthened its collaboration with Bio-Rad Laboratories. This expanded partnership focuses on developing and validating advanced in vitro diagnostic assays aimed at enhancing the detection of genomic markers in oncology applications. Utilizing Bio-Rad's renowned Droplet Digital™ PCR technology on its QX600 platform, Biodesix aims to create highly sensitive assays tailored for precise cancer diagnostics.

Cutting-Edge Assays for Oncology Applications

The initial assay being worked on under this partnership is the ddPLEX ESR1 Mutation Detection Assay. This assay holds significant potential as ESR1 testing is critical for managing HR+/HER2- advanced breast cancer. The technologies being utilized will allow for accurate detection and quantification of various ESR1 mutations within circulating tumor DNA (ctDNA) samples, which is vital for improving patient outcomes.

Supporting Biopharma and Clinical Clients

Once the validation process is complete, the ESR1 mutation assay will be available as a test service at Biodesix' accredited laboratory, which is CLIA-CAP certified. This offering aims to support biopharmaceutical companies in developing targeted therapies and assist clinical practitioners in monitoring cancer treatments effectively. Moreover, Biodesix plans to work closely with the Centers for Medicare & Medicaid Services (CMS) to explore reimbursement options for the assay, emphasizing its commitment to accessible healthcare innovations.

Leadership Insights on the Partnership

Scott Hutton, the CEO of Biodesix, expressed enthusiasm regarding the expanded partnership. "The emergence of ESR1 mutations as significant biomarkers has transformed the landscape of breast cancer treatment. We are eager to enhance our capabilities through this collaboration, ensuring rapid and sensitive assay development that meets clinical demands and paves the way for personalized medicine," he stated.

Ongoing Collaboration in the Oncology Field

Steve Kulisch, VP of Product Management at Bio-Rad Laboratories, commented on the long-standing relationship with Biodesix. He noted that their previous collaborations have effectively addressed both clinical and research applications, particularly in non-small cell lung cancer diagnostics. The advancement of the ddPLEX ESR1 kits represents another step forward in their mission to improve biomarker detection and patient outcomes for advanced breast cancer.

Upcoming Events and Presentations

Biodesix and Bio-Rad will be featuring their collaborative efforts and R&D visions at an upcoming conference. They will detail their partnership at the AMP conference, scheduled for mid-November in Boston, MA. This event will provide insights into their commercial strategies and future developments in clinical research.

About Biodesix

Biodesix is devoted to advancing diagnostic solutions that enhance patient care and clinical outcomes. Their products, such as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, are designed to assist healthcare providers in making informed decisions quickly. Furthermore, Biodesix Development Services empower top biopharmaceutical and life sciences organizations by providing essential support for developing innovative diagnostic tools and therapeutic solutions.

Contact Information for Biodesix

Media Inquiries:
Natalie St. Denis, Director of Corporate Communications
Email: natalie.stdenis@biodesix.com
Phone: (720) 925-9285

Investor Relations:
Chris Brinzey, Partner at ICR
Email: chris.brinzey@icrhealthcare.com
Phone: (339) 970-2843

Frequently Asked Questions

What is the focus of the partnership between Biodesix and Bio-Rad?

The partnership focuses on developing advanced diagnostic assays for oncology applications using Bio-Rad's ddPCR technology.

What is the significance of the ESR1 Mutation Detection Assay?

This assay is crucial for detecting mutations in HR+/HER2- advanced breast cancer, thereby aiding in patient treatment management.

How will the ESR1 assay benefit biopharma clients?

It will support biopharma clients in developing targeted therapies and monitoring treatment effectiveness.

What are the future plans for Biodesix regarding the ESR1 assay?

Biodesix plans to validate the assay and seek reimbursement options through CMS to ensure accessibility for patients.

What are Biodesix's main products?

Biodesix offers Nodify Lung for nodule risk assessment and IQLung for cancer treatment guidance, improving decision-making in clinical settings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 0

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 0

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 0

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 0

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Industries: The Future of AI with Dahua's Xinghan

Updated Category News Views 233

Dahua Technology Unveils Innovative AI Solutions Dahua Technology is at the forefront of video-centric AI and IoT solutions. The company has recently introduced the powerful Xinghan Large-scale AI Models, which represent a significant advancement in AI technology. These models are designed to tackle complex challenges in various sectors by integrating large-scale visual...

Continue Reading
Innovations in Payment Technologies: A Deep Dive Discussion

Updated Category News Views 209

An Insightful Overview of Emerging Payment Technologies Exploring the U.S. Payments Forum's Recent Findings The U.S. Payments Forum recently conducted a comprehensive summer market snapshot, gathering insights from prominent payment organizations during an extensive virtual educational series. This dynamic session attracted a broad spectrum of payment industry...

Continue Reading
Private Sector Employment Rises Despite Slower Momentum

Updated Category Economy Views 354

U.S. Business Activity Hits 27-Month High in July July's 27-month high in U.S. business activity suggests strong economic momentum. Rising from 54.8 in June to 55.0, the flash U.S. Composite PMI Output Index from S&P Global Since April 2022 this is the highest level. Tracking both manufacturing and services, the index has a reading above 50 suggesting growth. Driven by...

Continue Reading
Philips Advances Patient Care with Pioneering PAD Treatment

Updated Category News Views 28

Philips Leads the Way in Peripheral Artery Disease Treatment Philips has recently achieved a remarkable milestone in the realm of healthcare with the enrollment of the first patient in a groundbreaking clinical trial in the United States. This innovative trial focuses on an integrated device that utilizes cutting-edge laser technology to treat peripheral artery disease...

Continue Reading
HTX's Innovative Funds Bonus Trial Program Drives Crypto Growth

Updated Category News Views 87

HTX Introduces a Game-Changing Funds Bonus Trial Program HTX has officially launched its New Funds Bonus Trial Program, an innovative initiative aimed at rewarding users for their net new funds deposited on the platform. This groundbreaking program represents a shift from conventional commission models, focusing on creating lasting partnerships between the platform and...

Continue Reading